KINIKSA PHARMACEUTICALS, LTD. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.5 USD | +0.54% |
|
+11.30% | +11.74% |
| 23/04 | Kiniksa Pharmaceuticals Q1 Loss Widens, Revenue Rises | MT |
| 23/04 | Transcript : Kiniksa Pharmaceuticals, Ltd., Q1 2024 Earnings Call, Apr 23, 2024 |
Chart calendar Kiniksa Pharmaceuticals, Ltd.
c6471f13189bd56dcd1685f0e9d3b6.3Z0KMEo-EWP7ZSxBNcR82j-h2wVyzKxFTqjQBTihAEg.la5cHXNEICaOPER2d_QM91TxvlMRmuc2FuKDdEruajDsr0d8A0ZbDbYiaQ~29fed3844a65c578ce82df2ca8b2360c
Upcoming events on Kiniksa Pharmaceuticals, Ltd.
Past events on Kiniksa Pharmaceuticals, Ltd.
| 23/04/2024 06:00 pm | Q1 2024 Earnings Call |
| 23/04/2024 05:00 pm | Q1 2024 Earnings Release |
| 28/02/2024 07:00 pm | Q4 2023 Earnings Call |
| 28/02/2024 06:00 pm | Q4 2023 Earnings Release |
| 09/01/2024 03:00 am | JPMorgan Healthcare Conference |
| 31/10/2023 06:00 pm | Q3 2023 Earnings Call |
| 31/10/2023 05:00 pm | Q3 2023 Earnings Release |
| 25/07/2023 06:00 pm | Q2 2023 Earnings Call |
| 25/07/2023 05:00 pm | Q2 2023 Earnings Release |
| 13/06/2023 09:10 pm | Goldman Sachs Global Healthcare Conference |
| 06/06/2023 | Annual General Meeting |
| 02/05/2023 06:00 pm | Q1 2023 Earnings Call |
| 02/05/2023 05:00 pm | Q1 2023 Earnings Release |
| 28/02/2023 07:00 pm | Q4 2022 Earnings Call |
| 28/02/2023 06:30 pm | Q4 2022 Earnings Release |
| 10/01/2023 03:00 am | JP Morgan Healthcare Conference |
| 07/12/2022 08:45 pm | Bank of America Biotech SMID Cap Conference |
| 30/11/2022 08:35 pm | Evercore ISI HealthCONx Conference |
| 01/11/2022 06:00 pm | Q3 2022 Earnings Call |
| 01/11/2022 05:30 pm | Q3 2022 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 38,5 37,4 3.06% | 220 203 8.25% | 270 259 4.25% | 386 |
|
EBITDA Million USD | Released Forecast Spread | -168 -172 2.47% | -155 -147 -5.6% | -154 -147 -5.04% | 12,2 -10,6 214.86% | -22,9 -39,4 42.05% | -29,1 |
|
EBIT Million USD | Released Forecast Spread | -170 -173 1.53% | -157 -149 -5.32% | -157 -149 -5.32% | 9,77 -12,5 178.49% | -25,2 -34,7 27.37% | -10,5 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -164 -165 0.48% | -156 -147 -6.38% | -157 -151 -3.73% | 11,0 -11,8 193.73% | -16,7 -26,8 37.79% | -1,42 |
|
Net income Million USD | Released Forecast Spread | -162 -169 4.49% | -161 -149 -8.27% | -158 -149 -5.82% | 183 163 12.74% | 14,1 -21,3 166.13% | -7,91 |
|
EPS USD | Released Forecast Spread | -2,99 -3,02 0.91% | -2,61 -2,43 -7.56% | -2,30 -2,18 -5.59% | 2,60 2,29 13.44% | 0,20 -0,30 166.26% | -0,11 |
| Announcement Date | 26/02/20 | 23/02/21 | 22/02/22 | 28/02/23 | 28/02/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 32,2 28,1 14.64% | 27,0 28,6 -5.53% | 99,1 98,2 0.94% | 61,9 45,1 37.17% | 48,3 45,7 5.88% | 71,5 52,2 36.93% | 67,0 64,4 4.03% | 83,4 72,3 15.39% | 79,9 78,5 1.78% | 90,6 | 101 | 112 | 128 | 120 |
|
EBITDA Million USD | Released Forecast Spread | 0,62 -15,0 104.14% | -11,0 | -3,00 | -6,00 | ||||||||||
|
EBIT Million USD | Released Forecast Spread | -23,3 -28,0 16.71% | -19,4 -30,7 36.93% | 46,4 56,7 -18.1% | 6,05 -16,3 137.17% | -11,2 -16,8 33.52% | -3,15 -13,5 76.59% | -10,9 -15,3 28.61% | 0,08 -9,33 100.87% | -16,5 -12,5 -32.16% | -4,95 | -1,95 | -2,80 | 16,1 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -23,3 -27,2 14.31% | -19,3 -30,8 37.43% | 46,7 55,2 -15.37% | 6,84 -15,8 143.38% | -9,36 -14,7 36.26% | -1,24 -12,0 89.68% | -8,50 -15,5 45.19% | 2,45 -10,2 123.93% | -14,3 -9,57 -49.23% | -4,49 | -1,19 | 1,01 | ||
|
Net income Million USD | Released Forecast Spread | -25,2 -27,2 7.23% | -20,0 -30,1 33.63% | 224 54,4 312.1% | 4,46 -16,4 127.16% | -12,3 -12,6 2.7% | 15,0 -10,7 239.54% | -14,1 -12,9 -9.33% | 25,2 -7,96 416.97% | -17,7 -9,57 -85.06% | -4,49 | -1,19 | 0,97 | ||
|
EPS USD | Released Forecast Spread | -0,36 -0,33 -9.09% | -0,29 -0,44 34.34% | 3,18 0,78 306.95% | 0,06 -0,23 125.92% | -0,18 -0,21 12.89% | 0,21 -0,17 225.99% | -0,20 -0,17 -18.84% | 0,35 -0,14 348.46% | -0,25 -0,16 -51.75% | -0,09 | -0,04 | -0,03 | 0,10 | 0,03 |
| Announcement Date | 03/05/22 | 03/08/22 | 01/11/22 | 28/02/23 | 02/05/23 | 25/07/23 | 31/10/23 | 28/02/24 | 23/04/24 | - | - | - | - | - |
| Today 08:30 pm | GENMAB A/S: Q1 2024 Earnings Release |
| Today 01:31 am | ASCENDIS PHARMA A/S: Q1 2024 Earnings Release |
| 06/05/2024 | FRAZIER LIFESCIENCES ACQUISITION CORPORATION: Q1 2024 Earnings Release (Projected) |
| 06/05/2024 | KRYSTAL BIOTECH, INC.: Q1 2024 Earnings Release |
| 06/05/2024 | MERUS N.V.: Q1 2024 Earnings Release (Projected) |
| 06/05/2024 | VAXCYTE, INC.: Q1 2024 Earnings Release (Projected) |
| 06/05/2024 | INHIBRX, INC.: Q1 2024 Earnings Release (Projected) |
| 06/05/2024 | BIONTECH SE: Q1 2024 Earnings Release |
| 06/05/2024 04:30 pm | BIOCRYST PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 07/05/2024 01:31 am | VERTEX PHARMACEUTICALS INCORPORATED: Q1 2024 Earnings Release |
Past sector events for Kiniksa Pharmaceuticals, Ltd.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- KNSA Stock
- Calendar Kiniksa Pharmaceuticals, Ltd.
